92 related articles for article (PubMed ID: 20051799)
1. Activated recombinant factor VII and extracorporeal membrane oxygenation: everything is all right, nothing is wrong?
Dominguez TE; Brown KL
Pediatr Crit Care Med; 2010 Jan; 11(1):155-6. PubMed ID: 20051799
[No Abstract] [Full Text] [Related]
2. Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.
Niebler RA; Punzalan RC; Marchan M; Lankiewicz MW
Pediatr Crit Care Med; 2010 Jan; 11(1):98-102. PubMed ID: 19561557
[TBL] [Abstract][Full Text] [Related]
3. Fatal thrombosis with activated factor VII in a paediatric patient on extracorporeal membrane oxygenation.
Chalwin RP; Tiruvoipati R; Peek GJ
Eur J Cardiothorac Surg; 2008 Sep; 34(3):685-6. PubMed ID: 18579402
[TBL] [Abstract][Full Text] [Related]
4. Use of recombinant activated factor VII in children.
Hammer GB; Williams GD
Paediatr Anaesth; 2007 Dec; 17(12):1123-5. PubMed ID: 17986029
[No Abstract] [Full Text] [Related]
5. Relative risks of recombinant factor VII.
McMullan DM
Pediatr Crit Care Med; 2009 Sep; 10(5):604-5. PubMed ID: 19741450
[No Abstract] [Full Text] [Related]
6. Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.
Verrijckt A; Proulx F; Morneau S; Vobecky S
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1812-3. PubMed ID: 15173742
[No Abstract] [Full Text] [Related]
7. Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery.
Wittenstein B; Ng C; Ravn H; Goldman A
Pediatr Crit Care Med; 2005 Jul; 6(4):473-6. PubMed ID: 15982438
[TBL] [Abstract][Full Text] [Related]
8. Successful use of recombinant factor VIIa in a patient with intractable bleeding during extracorporeal membrane oxygenation.
Brose S; Sirbu H; Engel M; Kuhlen R; Autschbach R
Thorac Cardiovasc Surg; 2005 Dec; 53(6):389-90. PubMed ID: 16311981
[TBL] [Abstract][Full Text] [Related]
9. Use of activated recombinant factor VII in pediatric extracorporeal membrane oxygenation.
Walker A; Davidson M; Chalmers E
Pediatr Crit Care Med; 2010 Jul; 11(4):537-8; author reply 538-9. PubMed ID: 20606560
[No Abstract] [Full Text] [Related]
10. Recombinant activated factor VII in the management of massive obstetric bleeding.
Palomino MA; Chaparro MJ; de Elvira MJ; Curiel EB
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):226-7. PubMed ID: 16575264
[No Abstract] [Full Text] [Related]
11. Recombinant factor VIIa is a pan-hemostatic agent?
Aledort LM
Thromb Haemost; 2000 May; 83(5):637-8. PubMed ID: 10823252
[No Abstract] [Full Text] [Related]
12. Fatal Thrombosis After Factor VII Administration During Extracorporeal Membrane Oxygenation.
Swaminathan M; Shaw AD; Greenfield RA; Grichnik KP
J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):259-60. PubMed ID: 18375330
[No Abstract] [Full Text] [Related]
13. Off-label use of recombinant activated factor VII--safe or not safe?
Aledort LM
N Engl J Med; 2010 Nov; 363(19):1853-4. PubMed ID: 21047230
[No Abstract] [Full Text] [Related]
14. Recombinant factor VIIa: a universal hemostatic agent?
Lloyd JV; Joist JH
Curr Hematol Rep; 2002 Sep; 1(1):19-26. PubMed ID: 12901121
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of activated factor VII in postoperative bleeding after cardiac surgery with extracorporeal membrane oxygenation].
López-Herce Cid J; Arriola Pereda G; Zunzunegui Martínez JL; Brandstrup Azuero KB
An Pediatr (Barc); 2005 May; 62(5):471-4. PubMed ID: 15871830
[TBL] [Abstract][Full Text] [Related]
16. Low-dose heparin during extracorporeal membrane oxygenation treatment in adults.
Yeo HJ; Kim DH; Jeon D; Kim YS; Cho WH
Intensive Care Med; 2015 Nov; 41(11):2020-1. PubMed ID: 26271907
[No Abstract] [Full Text] [Related]
17. Caution with the use of recombinant activated factor VII in treating postoperative hemorrhage in cardiac surgery.
Al-Ruzzeh S; Mahmoud A; Shah S; O'Regan D
Ann Thorac Surg; 2007 Jan; 83(1):355; author reply 355-6. PubMed ID: 17184710
[No Abstract] [Full Text] [Related]
18. Recombinant activated factor VII for acute intracerebral hemorrhage.
Sheth KN
N Engl J Med; 2005 May; 352(20):2133-4; author reply 2133-4. PubMed ID: 15906433
[No Abstract] [Full Text] [Related]
19. Anticoagulation and coagulation management for ECMO.
Oliver WC
Semin Cardiothorac Vasc Anesth; 2009 Sep; 13(3):154-75. PubMed ID: 19767408
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
Jirapinyo M; Manonai J; Herabutya Y; Chuncharunee S
J Med Assoc Thai; 2007 May; 90(5):977-81. PubMed ID: 17596055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
